advent < adverse < adversely

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 86.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000005 (2007)	Sunil Kalia ; Jan P. Dutz	New concepts in antimalarial use and mode of action in dermatology
000029 (2012)	N. Ezra [États-Unis] ; J. Jorizzo [États-Unis]	Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus
000059 (1995)	Mark J. Borigini ; Harold E. Paulus	Combination therapy
000093 (2002)	Edna Patatanian [États-Unis] ; Dennis F. Thompson [États-Unis]	A Review of Methotrexate‐Induced Accelerated Nodulosis
000125 (1997)	O. Elkayam [États-Unis] ; M. Yaron [États-Unis] ; G. Zhukovsky [États-Unis] ; R. Segal [États-Unis] ; D. Caspi [États-Unis]	Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients
000142 (1990)	Kenneth M. Williams [Australie]	Enantiomers in arthritic disorders
000173 (2006)	Ting Li [République populaire de Chine] ; Shun-Le Chen [République populaire de Chine] ; Daniel E. Furst [États-Unis] ; Chun-De Bao [République populaire de Chine] ; Li Li [République populaire de Chine] ; Sheng Chen [République populaire de Chine]	A 1‐year study of two doses of steroid in combination with methotrexate and chloroquine in the treatment of patients with mild and moderate systemic lupus erythematosus
000220 (2012)	Pramote Tragulpiankit [Thaïlande] ; Suvatna Chulavatnatol ; Ticha Rerkpattanapipat [Thaïlande] ; Suchela Janwityanujit [Thaïlande] ; Suthatip Somjarit ; Uamporn Sirikhedgon	Adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients
000255 (1992)	Stephen E. Wolverton [États-Unis]	Monitoring for adverse effects from systemic drugs used in dermatology
000278 (2000)	Michael H. Schiff [États-Unis] ; Andrew Whelton [États-Unis]	Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis
000282 (2012)	Hayley Ipp [Afrique du Sud] ; Annalise E. Zemlin [Afrique du Sud] ; Richard H. Glashoff [Afrique du Sud] ; Johan Van Wyk [Afrique du Sud] ; Naadira Vanker [Afrique du Sud] ; Tim Reid [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud]	Serum Adenosine Deaminase and Total Immunoglobulin G Correlate with Markers of Immune Activation and Inversely with CD4 Counts in Asymptomatic, Treatment-Naive HIV Infection
000283 (1994)	E. Pussard [France] ; F. Verdier [France]	Antimalarial 4‐aminoquinolines: mode of action and pharmacokinetics
000293 (2008)		Reporting On Adverse Clinical Events
000295 (2002)	K. Pavelka [République tchèque] ; Š. Forejtová [République tchèque] ; A. Pavelková [République tchèque] ; J. Zvárová [République tchèque] ; J. Rovensk [République tchèque] ; A. Tuchy Ová [République tchèque]	Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics
000325 (1995)	M. Kloppenburg ; B. A. C. Dijkmans ; F. C. Breedveld	Antimicrobial therapy for rheumatoid arthritis
000345 (2012)	Eamonn S. Molloy [Irlande (pays)] ; Leonard H. Calabrese [États-Unis]	Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
000386 (2013)	Guillaume Pouessel [France] ; Antoine Deschildre [France] ; Muriel Le Bourgeois [France] ; Jean-Marie Cuisset [France] ; Benoit Catteau [France] ; Chantal Karila [France] ; Véronique Nève [France] ; Caroline Thumerelle [France] ; Pierre Quartier [France] ; Isabelle Tillie-Leblond [France]	The lung is involved in juvenile dermatomyositis
000397 (2001)	H. A. Shehata [Royaume-Uni] ; C. Nelson-Piercy [Royaume-Uni]	Connective tissue and skin disorders in pregnancy
000417 (2012)	Cheng-Tao Yang [Taïwan] ; Chang-Fu Kuo [Taïwan] ; Shue-Fen Luo [Taïwan] ; Kuang-Hui Yu [Taïwan]	Discontinuation of anti-TNF-α therapy in a Chinese cohort of patients with rheumatoid arthritis
000427 (2008)	J. Alijotas-Reig [Espagne] ; V. Garcia-Gimenez [Espagne]	Delayed immune‐mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long‐term follow‐up and review of the literature
000487 (1997)	U. Pedersen-Bjergaard ; M. Andersen ; P. B. Hansen	Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "adverse" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "adverse" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    adverse
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021